Catherine M. Albert

1.1k total citations
21 papers, 310 citations indexed

About

Catherine M. Albert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Catherine M. Albert has authored 21 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Catherine M. Albert's work include CAR-T cell therapy research (13 papers), Glioma Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Catherine M. Albert is often cited by papers focused on CAR-T cell therapy research (13 papers), Glioma Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Catherine M. Albert collaborates with scholars based in United States, Germany and France. Catherine M. Albert's co-authors include David M. Loeb, Roanne K. Karzon, Allison A. King, Robert J. Hayashi, Gregory McCarty, Masanori Hayashi, Kyle W. Jackson, Deepali Sachdev, Xianzheng Zhou and Xin Huang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Catherine M. Albert

21 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine M. Albert United States	9	210	118	83	57	52	21	310
Evan Weber Canada	8	70 0.3×	59 0.5×	90 1.1×	46 0.8×	12 0.2×	13	271
Stephanie Newman United States	7	134 0.6×	110 0.9×	123 1.5×	76 1.3×	11 0.2×	8	316
Mitchell Sun United States	8	110 0.5×	32 0.3×	170 2.0×	150 2.6×	44 0.8×	11	398
Sylvia L. van Egmond Netherlands	9	202 1.0×	30 0.3×	53 0.6×	163 2.9×	14 0.3×	14	342
Cegui Hu China	12	75 0.4×	71 0.6×	144 1.7×	52 0.9×	35 0.7×	21	339
Neil M. Neumann United States	9	169 0.8×	50 0.4×	221 2.7×	15 0.3×	50 1.0×	18	404
Caroline V.M. Verhagen Netherlands	11	136 0.6×	66 0.6×	127 1.5×	10 0.2×	12 0.2×	14	306
Yuhao Shi China	9	125 0.6×	33 0.3×	244 2.9×	44 0.8×	16 0.3×	18	475
Ruoshi Shi China	9	175 0.8×	99 0.8×	103 1.2×	23 0.4×	84 1.6×	11	345
Stavros Polyzoidis United Kingdom	6	82 0.4×	65 0.6×	108 1.3×	109 1.9×	10 0.2×	9	269

Countries citing papers authored by Catherine M. Albert

Since Specialization

Citations

This map shows the geographic impact of Catherine M. Albert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine M. Albert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine M. Albert more than expected).

Fields of papers citing papers by Catherine M. Albert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine M. Albert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine M. Albert. The network helps show where Catherine M. Albert may publish in the future.

Co-authorship network of co-authors of Catherine M. Albert

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine M. Albert. A scholar is included among the top collaborators of Catherine M. Albert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine M. Albert. Catherine M. Albert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2024). STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors. Journal of Clinical Oncology. 42(35). 4163–4172. 14 indexed citations

Ronsley, Rebecca, Michelle Choe, Kristy Seidel, et al.. (2024). IMMU-01. PIONEERING QUAD-TARGETING CAR T CELL THERAPY IN PEDIATRIC CNS TUMORS – ANALYSIS FROM THE INITIAL PATIENTS TREATED ON THE FIRST-IN-HUMAN PHASE 1 TRIAL BRAINCHILD-04. Neuro-Oncology. 26(Supplement_4). 0–0. 1 indexed citations

Choe, Michelle, Mallory Taylor, Jason Wendler, et al.. (2024). STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.. Journal of Clinical Oncology. 42(16_suppl). e14626–e14626. 1 indexed citations

Rudzinski, Erin R., Sandra D. Bohling, Yajuan J. Liu, et al.. (2023). CD43-positive, EWSR1::FLI1-rearranged Soft Tissue Sarcoma in a Pediatric Patient With History of B-Cell Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 45(5). e635–e638. 1 indexed citations

Albert, Catherine M., Navin Pinto, Mallory Taylor, et al.. (2023). ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.. Journal of Clinical Oncology. 41(16_suppl). TPS11581–TPS11581. 4 indexed citations

Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2023). Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment.. Journal of Clinical Oncology. 41(16_suppl). 10043–10043. 2 indexed citations

Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2022). STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 10011–10011. 23 indexed citations

Mascarenhas, Leo, Cornelis M. van Tilburg, François Doz, et al.. (2022). Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer: An expanded dataset.. Journal of Clinical Oncology. 40(16_suppl). 10030–10030. 8 indexed citations

Albert, Catherine M., Navin Pinto, Mallory Taylor, et al.. (2022). STRIvE-01: Phase I study of EGFR806 CAR T-cell immunotherapy for recurrent/refractory solid tumors in children and young adults.. Journal of Clinical Oncology. 40(16_suppl). 2541–2541. 13 indexed citations

10.

Vitanza, Nicholas A., Ashley Wilson, Juliane Gust, et al.. (2021). IMMU-11. CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLS. Neuro-Oncology. 23(Supplement_1). i29–i29. 8 indexed citations

11.

Albert, Catherine M., et al.. (2021). Recurrent Severe Staphylococcus epidermidis Urinary Tract Infections in a 7-Year-Old Boy. Clinical Pediatrics. 60(8). 346–349. 3 indexed citations

12.

Kummar, Shivaani, Cornelis M. van Tilburg, Catherine M. Albert, et al.. (2020). Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population.. Journal of Clinical Oncology. 38(15_suppl). 3614–3614. 6 indexed citations

13.

Vitanza, Nicholas A., Juliane Gust, Ashley Wilson, et al.. (2020). IMMU-03. UPDATES ON BRAINCHILD-01, -02, AND -03: PHASE 1 LOCOREGIONAL CAR T CELL TRIALS TARGETING HER2, EGFR, AND B7-H3 FOR CHILDREN WITH RECURRENT CNS TUMORS AND DIPG. Neuro-Oncology. 22(Supplement_3). iii360–iii360. 5 indexed citations

14.

Drilon, Alexander, Cornelis M. van Tilburg, Anna F. Farago, et al.. (2020). Abstract CT199: Larotrectinib in TRK fusion cancer patients: Outcomes by prior therapy and performance status. Cancer Research. 80(16_Supplement). CT199–CT199. 2 indexed citations

15.

Albert, Catherine M. & Seth M. Pollack. (2019). Immunotherapy for synovial sarcoma. AIMS Medical Science. 6(3). 191–200. 1 indexed citations

16.

Crotty, Erin, et al.. (2019). Atraumatic Spinal Epidural Hematoma as Initial Presentation of Hemophilia A in an Infant. Pediatric Emergency Care. 37(11). e772–e774. 1 indexed citations

17.

Hayashi, Masanori, Alissa C. Baker, Seth D. Goldstein, et al.. (2017). Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma. Oncotarget. 8(45). 78265–78276. 24 indexed citations

18.

Hayashi, Masanori, Peixuan Zhu, Gregory McCarty, et al.. (2017). Size-based detection of sarcoma circulating tumor cells and cell clusters. Oncotarget. 8(45). 78965–78977. 46 indexed citations

19.

Huang, Xin, Haein Park, J.T. Greene, et al.. (2015). IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. PLoS ONE. 10(7). e0133152–e0133152. 88 indexed citations

20.

Albert, Catherine M., et al.. (2008). Hearing Loss in Pediatric Oncology Patients Receiving Carboplatin-containing Regimens. Journal of Pediatric Hematology/Oncology. 30(2). 130–134. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact